Fintel reports that on September 5, 2025, Baird initiated coverage of Hinge Health (NYSE:HNGE) with a Neutral recommendation.

Analyst Price Forecast Suggests 14.59% Upside

As of September 3, 2025, the average one-year price target for Hinge Health is $64.18/share. The forecasts range from a low of $57.57 to a high of $73.50. The average price target represents an increase of 14.59% from its latest reported closing price of $56.01 / share.

See our leaderboard of companies with the largest price target upside.

The projected annual non-GAAP EPS is 0.66.

What are Other Shareholders Doing?

Insight Holdings Group holds 11,030K shares representing 40.52% ownership of the company.

Coatue Management holds 4,702K shares representing 17.27% ownership of the company.

Alyeska Investment Group holds 1,363K shares representing 5.01% ownership of the company.

Vitruvian Partners LLP holds 1,250K shares representing 4.59% ownership of the company.

Bamco holds 946K shares representing 3.47% ownership of the company.